ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2025

Serum LEAP2 Levels Across the Spectrum of Metabolic Dysfunction-Associated Fatty Liver Disease: A Potential Noninvasive Biomarker for Severity Stratification.

Xinyang Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.